Productivity Shocks to the Pharmaceutical Sector and the Danish Economy: Denmark

December 24, 2024

Download PDF More Formats on IMF eLibrary Order a Print Copy

More formats on IMF eLibrary Order a Print Copy

Preview Citation

Format: Chicago

Takuji Komatsuzaki. "Productivity Shocks to the Pharmaceutical Sector and the Danish Economy: Denmark", Selected Issues Papers 2024, 043 (2024), accessed January 13, 2025, https://doi.org/10.5089/9798400296383.018

Export Citation

ProCite
RefWorks
Reference Manager

BibTex
Zotero

EndNote

Summary

The pharmaceutical industry in Denmark has grown rapidly in recent years. This paper discusses the macroeconomic impact of the pharmaceutical sector. The analysis focuses on Novo Nordisk, the leading pharmaceutical company in Denmark, and its productivity impact on the rest of the economy. Empirical evidence suggests only weak correlations between productivity shocks at Novo Nordisk and overall economic growth, as well as between Novo Nordisk’s productivity and that of other firms. However, we find evidence of a significant within-industry spillover effect in the pharmaceutical sector.

Subject: Employment, Exports, International trade, Labor, Labor productivity, Production, Productivity

Keywords: Employment, Exports, Global, Labor productivity, Macroeconomic impact, Novo Nordisk's productivity, Pharmaceutical, Pharmaceutical industry in Denmark, Productivity, Productivity shock, Shocks to Novo Nordisk, Spillovers

Publication Details

Pages:

16
Volume:

2024
DOI:

https://doi.org/10.5089/9798400296383.018
Issue:

043
Series:

Selected Issues Paper No. 2024/043
Stock No:

SIPEA2024043
ISBN:

9798400296383
ISSN:

2958-7875

FACTSHEETS

RESOURCES

TOPICS

Flagship Publications

Other Publications

IMF reports and publications by country

Regional Offices

All News

See Also

For Journalists

Press Center

RESOURCES

FLAGSHIPS

KEY SERIES

IMF NOTES

Selected Issues Papers